DENDREON TARGETING CANCER, TRANSFORMING LIVES - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
90260940
Word Mark
DENDREON TARGETING CANCER, TRANSFORMING LIVES
Status
730 - First Extension - Granted
Status Date
2021-12-15
Filing Date
2020-10-17
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
031702, 261709 - Feathers. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2021-04-20
Attorney Name
Law Office Assigned Location Code
N90
Employee Name
HOWARD, PARKER WALDRIP
Statements
Description of Mark
The mark consists of the term "Dendreon" having an upper case "D" and lower case "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e", "o" and "n" the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n" resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.
Goods and Services
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-12-04
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Diane L. Gardner
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 2465920 |
Prior Registration | 2530065 |
Trademark Events
Event Date | Event Description |
2020-10-21 | NEW APPLICATION ENTERED IN TRAM |
2020-12-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-12-05 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2021-03-08 | ASSIGNED TO EXAMINER |
2021-03-12 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-03-31 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-04-20 | PUBLISHED FOR OPPOSITION |
2021-04-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-06-15 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-12-15 | TEAS EXTENSION RECEIVED |
2021-12-15 | EXTENSION 1 FILED |
2021-12-15 | EXTENSION 1 GRANTED |
2021-12-17 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |